Endo USA, Inc. is recalling approximately 113,331 cartons of PAR Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (0.125 mg, 0.25 mg, 1 mg, and 2 mg strengths). Some cartons were incorrectly labeled with the wrong medication strength on the outside packaging, although the individual blister strips inside the carton reflect the correct strength. This error could lead patients to take a different dose than prescribed by their healthcare provider.
A labeling error on the carton could result in a patient taking more or less medication than intended. This may lead to serious health consequences, such as respiratory depression, excessive sedation, or withdrawal symptoms if the dose is significantly lower than required.
You have 2 options:
Distributed by PAR Pharmaceutical; 10 blister cards containing 6 tablets each per carton.
Distributed by PAR Pharmaceutical; 10 blister cards containing 6 tablets each per carton.
Distributed by PAR Pharmaceutical; 10 blister cards containing 6 tablets each per carton.
Distributed by PAR Pharmaceutical; 10 blister cards containing 6 tablets each per carton.
“PAR Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP, 1 mg, 60 Tablets”
“Carton side label, shows Lot 550176501, EXP 2027-02”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.